Profil Sensitivitas Antibiotik Bakteri Penyebab Infeksi Saluran Kemih Terkait Kateter di Kota Mataram
DOI:
https://doi.org/10.33651/jpkik.v11i2.727Keywords:
Urinary tract infection, catheter, ciprofloxacin, sulphamethoxazole trimethoprim, antibiotic sensitivityAbstract
Urinary tract infection (UTI) is defined as an infection caused by the growth of microorganisms in the urinary tract. One risk factor for urinary tract infection is catheterization. Treatment of UTI involves antibiotics. However, antibiotic resistance is currently increasing. This is a descriptive, observational study aimed at determining antibiotic sensitivity to bacteria causing catheter-associated urinary tract infections in Mataram City. The method used for sensitivity testing was Kirby-Bauer disk diffusion. The antibiotics tested were Ciprofloxacin and Sulphamethoxazole trimethoprime. This study used 60 urine samples from patients with UTI with catheterization. The results of the study after bacterial identification showed that 53.33% were gram-positive bacteria and 46.67% were gram-negative bacteria. The results of the ciprofloxacin antibiotic sensitivity test showed that the bacteria had inhibition zone diameters with resistant, intermediate, and sensitive categories of 36.67%, 46.67%, and 16.66%, respectively. The antibiotic sulphamethoxazole trimethoprime obtained bacteria with resistant, intermediate, and sensitive inhibition zone diameter categories of 5%, 23.33%, and 71.67%, respectively. From the results of this study, it can be concluded that bacteria causing catheterization-related urinary tract infections still show sensitivity to the antibiotic sulphamethoxazole trimethoprime compared to the antibiotic ciprofloxacin.
References
Mancuso G, Midiri A, Gerace E, Marra M, Zummo S, Biondo C. Urinary Tract Infections: The Current Scenario and Future Prospects. Vol. 12, Pathogens. MDPI; 2023.
Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: Epidemiology, mechanisms of infection and treatment options. Vol. 13, Nature Reviews Microbiology. Nature Publishing Group; 2015. p. 269–84.
Letica-Kriegel AS, Salmasian H, Vawdrey DK, Youngerman BE, Green RA, Furuya EY, et al. Identifying the risk factors for catheter-associated urinary tract infections: A large cross-sectional study of six hospitals. BMJ Open. 2019 Feb 1;9(2).
Naber KG, Tirán-Saucedo J, Wagenlehner FME. Psychosocial burden of recurrent uncomplicated urinary tract infections. GMS Infectious Disease. 2022;10.
Mancini A, Pucciarelli S, Lombardi FE, Barocci S, Pauri P, Lodolini S. Differences 1. Mancuso G, Midiri A, Gerace E, Marra M, Zummo S, Biondo C. Urinary Tract Infections: The Current Scenario and Future Prospects. Vol. 12, Pathogens. MDPI; 2023.
Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: Epidemiology, mechanisms of infection and treatment options. Vol. 13, Nature Reviews Microbiology. Nature Publishing Group; 2015. p. 269–84.
Letica-Kriegel AS, Salmasian H, Vawdrey DK, Youngerman BE, Green RA, Furuya EY, et al. Identifying the risk factors for catheter-associated urinary tract infections: A large cross-sectional study of six hospitals. BMJ Open. 2019 Feb 1;9(2).
Naber KG, Tirán-Saucedo J, Wagenlehner FME. Psychosocial burden of recurrent uncomplicated urinary tract infections. GMS Infectious Disease. 2022;10.
Mancini A, Pucciarelli S, Lombardi FE, Barocci S, Pauri P, Lodolini S. Differences between Community-and Hospital-acquired urinary tract infections in a tertiary care hospital. Vol. 43, O.U. Clinical Pathology. 2020.
Bader MS, Loeb M, Leto D, Brooks AA. Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents. Vol. 132, Postgraduate Medicine. Taylor and Francis Inc.; 2020. p. 234–50.
Rubi H, Mudey G, Kunjalwar R. Catheter-Associated Urinary Tract Infection (CAUTI). Cureus [Internet]. 2022 Oct 17; Available from: https://www.cureus.com/articles/112836-catheter-associated-urinary-tract-infection-cauti
Habboush Y, & GN. Antibiotic Resistance. Treasure Island (FL): StatPearls Publishing.; 2023.
Ihsan S. Analisis Rasionalitas Antibiotik Di Fasilitas Pelayanan Kesehatan. Deepublish; 2022.
Welcome I, They C. Advanced Infection Prevention and Control Training Prevention of catheter-associated urinary tract infection ( CAUTI ): student handbook Advanced Infection Prevention and Control Training. 2018;2016(January).
Kausuhe J, Pangemanan DHC, Onibala F, Studi P, Keperawatan I, Kedokteran F, et al. Hubungan Pemasangan Kateter Urine Dengan Kejadian Infeksi Saluran Kemih Di Rsu Gmim Pancaran Kasih Manado. Jurnal Keperawatan. 2017;5(2).
Walker JN, Flores-Mireles AL, Pinkner CL, Schreiber HL, Joens MS, Park AM, et al. Catheterization alters bladder ecology to potentiate Staphylococcus aureus infection of the urinary tract. Proc Natl Acad Sci U S A. 2017;114(41):E8721–30.
Hollenbeak CS, Schilling AL. The attributable cost of catheter-associated urinary tract infections in the United States: A systematic review. Am J Infect Control [Internet]. 2018;46(7):751–7. Available from: https://doi.org/10.1016/j.ajic.2018.01.015
Shuman EK, Chenoweth CE. Urinary Catheter-Associated Infections. Vol. 32, Infectious Disease Clinics of North America. W.B. Saunders; 2018. p. 885–97.
Tenke P, Mezei T, B?de I, Köves B. Catheter-associated Urinary Tract Infections. European Urology, Supplements. 2017;16(4):138–43.
Rawal G, Yadav S, Sujana R. Catheter associated urinary tract infection ( CAUTI )— Prevention better than cure Catheter associated urinary tract infection ( CAUTI ) — Prevention better than cure. 2017;(June).
Tenke P, Mezei T, B?de I, Köves B. Catheter-associated Urinary Tract Infections. European Urology, Supplements. 2017;16(4):138–43.
Grabe M, Bartoletti R, Bjerklund-Johansen TE, Cai T, Çek M, Koves B, et al. Guidelines on Urological Infections. European Association of Urology [Internet]. 2020;33–40. Available from: http://www.uroweb.org/gls/pdf/15_Urological_Infections.pdf
Nigussie D, Amsalu A. Prevalence of uropathogen and their antibiotic resistance pattern among diabetic patients. Turk Uroloji Dergisi. 2017;43(1):85–92.
Zilberberg MD, Nathanson BH, Sulham K, Shorr AF. Multiple antimicrobial resistance and outcomes among hospitalized patients with complicated urinary tract infections in the US, 2013–2018: a retrospective cohort study. BMC Infect Dis. 2021 Dec 1;21(1).
Ham DC, Fike L, Wolford H, Lastinger L, Soe M, Baggs J, et al. Trimethoprim-sulfamethoxazole resistance patterns among Staphylococcus aureus in the United States, 2012-2018. Infect Control Hosp Epidemiol. 2023 May 15;44(5):794–7.
Saini H, Vadekeetil A, Chhibber S, Harjai K. Azithromycin-ciprofloxacin-impregnated urinary catheters avert bacterial colonization, biofilm formation, and inflammation in a murine model of foreign-body-associated urinary tract infections caused by Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2017 Mar 1;61(3).
Osman M, Chusri S, Heidary M, Khoshnood S. The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic.
Sharma D, Patel RP, Zaidi STR, Sarker MMR, Lean QY, Ming LC. Interplay of the quality of ciprofloxacin and antibiotic resistance in developing countries. Vol. 8, Frontiers in Pharmacology. Frontiers Media S.A.; 2017.
Published
How to Cite
Issue
Section
Copyright (c) 2025 Baiq Isti Hijriani, Rubiyatma Sakaroni, Wirdullutfi Wirdullutfi
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
JPKIK : Jurnal Peneliian dan Kajian Ilmiah kesehatan is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License
You are free to :
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material for any purpose, even commercially
Under the following terms :
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits
